Hepatitis C – HCV Guidance

National trends and outcomes of heart-kidney transplantation using hepatitis C positive donors

August 23, 2022
Outcomes of Hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: a large single center analysis

August 23, 2022
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics

August 22, 2022
Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension

August 22, 2022
Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation.

August 17, 2022
Efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 4 infection: a pooled analysis

August 7, 2018
Hepatitis C screening of the "birth cohort" (born 1945-1965) and younger inmates of New York City jails

April 20, 2018
Opt-out HIV and hepatitis C testing at the Dallas county jail: uptake, prevalence, and demographic characteristics of testers

April 20, 2018
A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections

April 20, 2018
Is antenatal screening for hepatitis C virus cost-effective? A decade’s experience at a London centre

April 19, 2018